Esbriet

Esbriet (Pirfenidone) is a medication used to manage certain lung conditions. This oral treatment is designed to support respiratory health and is manufactured by Roche Registration Gmbh.

Esbriet is primarily used for the treatment of idiopathic pulmonary fibrosis (IPF), a condition characterized by progressive scarring of the lungs. It is often prescribed to slow the decline in lung function. Patients may wonder, 'What is Esbriet used for?' and the answer lies in its ability to help manage symptoms and improve quality of life for those with specific lung diseases.

Common effects of Esbriet may include nausea, rash, and fatigue. Some users report gastrointestinal discomfort, which can vary in severity. It is important to monitor any adverse reactions and consult a healthcare provider if they persist or worsen.

Esbriet should be handled with care, especially for individuals with liver or kidney issues. Regular monitoring of liver function is recommended. Patients should avoid activities that may increase the risk of sunburn, as the medication can increase sensitivity to sunlight.

Esbriet may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform healthcare providers about all current medications, including over-the-counter drugs and supplements. Alcohol consumption should be moderated, as it may exacerbate side effects.